Log In

Το IBRANCE (Palbociclib) έλαβε έγκριση στην Ευρώπη

Palbociclib, sold under the brand name Ibrance among others, is a medication for the treatment of HR-positive and HER2-negative breast cancerdeveloped by Pfizer. It is a selective inhibitor of the cyclin-dependent kinasesCDK4 and CDK6.[1][2] Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.[3] Mechanism of action Further information: CDK inhibitor It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.[1][2] In the G1 phase of the cell cycle, mammalian cells…

My work only allows Internet Explorer, so I have to manually

The model is talking about booking her latest gig, modeling WordPress underwear in the brand latest Perfectly Fit campaign, which was shot by Lachian Bailey. It was such a surreal moment cried she admitted. The main thing that you have to remember on this journey is just be nice to everyone and always smile. It’s…

Newsletter

footer

copyrights HTML